Kazia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.About KZIA
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer.
CEOJohn E. Friend
CEOJohn E. Friend
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1994
Founded1994
Employees—
Employees—
KZIA Key Statistics
Market cap140.51M
Market cap140.51M
Price-Earnings ratio-1.83
Price-Earnings ratio-1.83
Dividend yield—
Dividend yield—
Average volume183.14K
Average volume183.14K
High today$12.94
High today$12.94
Low today$12.01
Low today$12.01
Open price$12.64
Open price$12.64
Volume110.03K
Volume110.03K
52 Week high$17.40
52 Week high$17.40
52 Week low$3.41
52 Week low$3.41
KZIA News
TipRanks 1d
Kazia Therapeutics Expands Phase 1b Paxalisib Trial in Advanced Triple-Negative Breast CancerUnlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.